In March 2026, the Yale Journal of Biology & Medicine will be publishing an issue devoted to the topic of Neurodevelopment and Neurodegeneration. Continue to read to learn about the full call for manuscripts below and more information about the issue.
YJBM is a PubMed-indexed, open-access journal whose mission is to provide graduate students and medical students with experience in writing, reviewing, and publishing articles. The journal has been in publication since 1928 and is supported by an Editorial Board made up of students and faculty members. Manuscripts are peer-reviewed by faculty in the field and there is no publication fee. YJBM has a Scopus CiteScore of 5.0 for 2023 and an Impact Factor of 2.6 for 2023.


Call for Manuscripts – Neurodevelopment and Neurodegeneration Issue
Submission Deadline: December 8th, 2025
Publication Date: March 2026
The Yale Journal of Biology and Medicine (YJBM) is pleased to announce a forthcoming issue focused on Neurodevelopment and Neurodegeneration. We invite authors to submit papers addressing topics spanning cellular and molecular, systems, computational, and cognitive neuroscience.
Topics of Interest Include (but are not limited to):
- Diseases and Disorders
- Comparative Neurobiology
- Shared Mechanisms Underlying Neurodevelopment and Neurodegeneration
- Neuroethics of Emerging Technologies
- Neuroadaptive Responses
- Neuroinflammation
- Cell Type-Specific Vulnerabilities
Manuscript Submission Guidelines
- Manuscript Types: YJBM accepts original research articles (including negative results), review articles, case reports, and perspectives. Each type has specific formatting requirements.
- Formatting: Manuscripts should be double-spaced with numbered pages. Include an abstract of up to 250 words summarizing the study.
- References: Use the NLM citation style for references, listing all authors when possible. In-text citations should be numbered sequentially using brackets.
- Figures, Tables, and Images: Submit figures, tables, and images separately, with appropriate captions and labels. Ensure high-quality images and number tables and figures consecutively.
- Ethical Considerations: All research involving human subjects must include ethical approvals and informed consent statements.
As part of YJBM’s equity efforts, we offer double-blind peer review. Reviewer bias (conscious or otherwise) should not affect the science that is published. While we encourage you to submit an anonymized manuscript, we also accept unblinded submissions for single-blind review, where only the reviewer names are kept anonymous. For detailed instruction on manuscript preparation and submission, please refer to the YJBM Manuscript Submission Guidelines.
Deadline for Submissions: Please submit manuscripts by December 8, 2025 through our Scholastica submission page. Submissions should offer rigorous scholarship and contribute novel insights. We encourage early submissions for preliminary feedback.
Website: https://medicine.yale.edu/yjbm/
Manuscript submission portal: https://yjbm.scholasticahq.com/for-authors
Thank you to Nu Rho Psi member, Elaine Yang, for submitting this opportunity! Elaine Yang is a medical student at Yale University, and Deputy Editor of the Neurodevelopment & Neurodegeneration Issue for the YJBM!
Podcast: https://open.spotify.com/show/4bHLkESLGHhyWJOPIik37y
Instagram: https://www.instagram.com/theyjbm/
Bluesky: https://bsky.app/profile/theyjbm.bsky.social
Discover more from Nu Rho Psi
Subscribe to get the latest posts sent to your email.
